| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.5 | 0.05 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.21 | 0.6 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.3 |